Drug class
Short-acting non-depolarising neuromuscular blocking agent; benzylisoquinolinium compound
Mechanism of action
Competitively antagonises nicotinic acetylcholine receptors at the motor end-plate, blocking neuromuscular transmission. It is rapidly hydrolysed by plasma cholinesterase.
General use cases
- Adjunct to general anaesthesia to relax skeletal muscles and facilitate tracheal intubation and mechanical ventilation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
